The majority of high-grade ovarian cancers involve mutations in the p53 tumor suppressor gene, crucial for DNA repair and cell regulation. Researchers now developed a synthetic mRNA that successfully produced functional p53 protein in laboratory conditions, showing promise in cancer cell lines.
Researchers devised a method to deliver mRNA into the brain using lipid nanoparticles, potentially advancing treatments for Alzheimer's disease and seizures.
